As GLP-1 drugs like Ozempic and Wegovy shift consumer eating habits, how should producers in the bakery and snacks sectors pivot to stay relevant?
Our senior commodity specialist at WNS Procurement, Sheleena Jain, shares how GLP-1 drugs like Ozempic and Wegovy are reshaping demand in the bakery and snack sectors. GLP-1 users are opting for lower-calorie, nutrient-rich snacks like fruit-based options and sugar substitutes. She also recommends F&B companies consider using AI and data analytics to better understand consumer preferences.
Read the full coverage here.